Host Gasdermin D restrains systemic endotoxemia by capturing Proteobacteria in the colon of high-fat diet-feeding mice

Gut Microbes. 2021 Jan-Dec;13(1):1946369. doi: 10.1080/19490976.2021.1946369.

Abstract

Gasdermin D (GSDMD) functions as a key pyroptotic executor through its secreted N-terminal domain (GSDMD-N). However, the functional relevance and mechanistic basis of the precise roles of host colonic GSDMD in high-fat diet (HFD)-induced gut dysbiosis and systemic endotoxemia remain elusive. In this study, we demonstrate that HFD feeding triggers GSDMD-N secretion of both T-lymphocytes and enterocytes in mouse colons. GSDMD deficiency aggravates HFD-induced systemic endotoxemia, gut barrier impairment, and colonic inflammation. More importantly, active GSDMD-N kills the Proteobacteria phylum via directly interacting with Cardiolipin. Mechanistically, we identify that the Glu236 (a known residue for GSDMD protein cleavage) is a bona fide important site for the bacterial recognition of GSDMD. Collectively, our findings explain the mechanism by which colonic GSDMD-N maintains low levels of HFD-induced metabolic endotoxemia. A GSDMD-N mimetic containing an exposed Glu236 site could be an attractive strategy for the treatment of HFD-induced metabolic endotoxemia.

Keywords: Cardiolipin; Gasdermin D; Proteobacteria; host and microbiota crosstalk; metabolic endotoxemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiolipins / analysis
  • Colon / microbiology*
  • Diet, High-Fat / adverse effects
  • Disease Models, Animal
  • Dysbiosis / chemically induced*
  • Dysbiosis / drug therapy*
  • Endotoxemia / chemically induced*
  • Endotoxemia / drug therapy*
  • Gastrointestinal Microbiome / drug effects
  • Humans
  • Mice
  • Neoplasm Proteins / pharmacokinetics*
  • Neoplasm Proteins / therapeutic use*
  • Proteobacteria / drug effects*

Substances

  • Cardiolipins
  • Neoplasm Proteins

Grants and funding

This work was financially supported by grants from the National Natural Science Foundation of China [31800992, 81800512, 92057112, 31771298, and 81774248], The Natural Science Foundation of Jiangsu Province [BK20180554, BK20180577], The Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University [SKLNMZZRC202005], The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX19_0660].